Panacea Life Sciences Holdings, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $2.1M | $9.6M | $18.4K |
| FY2020 | $5.0M | $6.8M | $84.4K |
| FY2021 | $16.7M | $23.8M | $19.8K |
| FY2022 | $21.6M | $19.5M | $7.0K |
| FY2023 | $26.3M | $18.0M | $100.9K |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $2.1M | $9.6M | $18.4K |
| FY2020 | $5.0M | $6.8M | $84.4K |
| FY2021 | $16.7M | $23.8M | $19.8K |
| FY2022 | $21.6M | $19.5M | $7.0K |
| FY2023 | $26.3M | $18.0M | $100.9K |